India 2017 Tarceva purchasing agent 18210766570 Tarceva sales price

The consultation hotline Tarceva must be used under the guidance of doctors who have experience in using such drugs, and can only be used in the national clinical trial pharmacology base or tertiary A hospitals. The recommended dose of erlotinib monotherapy for non-small cell lung cancer is m/day, taken at least one hour before or one hour after eating. Continue treatment until disease progression or intolerable toxicity occurs. There is no evidence that patients benefit from continuing treatment after progression.
Dose adjustment: In patients with new acute attacks or progressive pulmonary symptoms, such as dyspnea, cough, and fever, erlotinib treatment should be suspended for diagnostic evaluation. If D (interstitial lung disease) is diagnosed, erlotinib should be discontinued and appropriate treatment given. Diarrhea is usually controlled with loperamide. Patients with severe diarrhea who are refractory to loperamide or who become dehydrated require dose reduction and temporary discontinuation of treatment. Patients with severe skin reactions may also require dose reduction and temporary discontinuation of treatment. If dose reduction is necessary, erlotinib should be reduced by m each time.
Concomitant use of strong inhibitors such as atazanavir, clarithromycin, indinavir, itraconazole, ketoconazole, nefazodone, nelfinavir, ritonavir, saquinavir Dose reduction should be considered when using drugs such as navir, telithromycin, ditroleandomycin, and voriconazole, otherwise serious adverse events may occur.
Using the induction agent rifampicin before treatment can reduce the effect of erlotinib. Alternative treatments without induction activity should be considered. If alternative treatments are not available, doses of erlotinib higher than m should be considered. If the dose of erlotinib is increased, the dose should be reduced when rifampicin or other inducers are discontinued. Other inducers include, but are not limited to, rifabutin, rifapentine, phenytoin, carbamazepine, phenobarbital, and St. John's wort, and these should also be avoided if possible. Erlotinib is eliminated by hepatic metabolism and biliary secretion. Erlotinib should therefore be used with caution in patients with liver dysfunction. If serious adverse reactions occur, erlotinib dose reduction or suspension should be considered. ,) Among the latest oral targeted therapy drugs for non-small cell lung cancer, clinical studies have confirmed that it is the only targeted therapy drug that can significantly prolong the survival of lung cancer patients. Tarceva's mode of action is different from that of chemotherapy. It is a targeted therapy drug that can specifically target tumor cells and inhibit the formation and growth of tumors. It is a small molecule compound that can inhibit the signaling pathway of human epidermal growth factor receptor (R). It is a key component of the epidermal growth factor (also known as) signaling pathway and plays a role in the formation and growth of various tumor cells. All played an important role. Tarceva inhibits tumor growth by inhibiting the activity of tyrosine kinase, which is one of the important components in R cells.
,)
,) Tarceva is a small molecule compound that can inhibit the signaling pathway of human epidermal growth factor receptor (R). It is the epidermal growth factor (also known as) signaling pathway. Key components play an important role in the formation and growth of various tumor cells. Tarceva inhibits tumor growth by inhibiting the activity of tyrosine kinases, thereby achieving the treatment of lung cancer.
,)
,)What is the mechanism of action of Tarceva? Tarceva's mode of action is different from that of chemotherapy. It is a targeted therapy drug that can specifically target tumor cells and inhibit the formation and growth of tumors. It is a small molecule compound that can inhibit the signaling pathway of human epidermal growth factor receptor (R). It is a key component of the epidermal growth factor (also known as) signaling pathway and plays a role in the formation and growth of various tumor cells. All played an important role. Tarceva inhibits tumor growth by inhibiting the activity of tyrosine kinase, which is one of the important components in R cells.
,)
,) Tarceva is a small molecule oral epidermal growth factor receptor tyrosine kinase inhibitor with higher affinity for the target and stronger specificity. Phase III clinical studies (BR.) have proven that it can significantly prolong the survival of various types of patients as a second/third-line treatment. Currently, Tarceva has been approved for advanced second-line/third-line treatment in more than 10 countries around the world.
,)
,)So, how much does Tarceva cost? When it comes to the price of Tarceva in India, the price of Roche Tarceva as a genuine product is definitely high. Of course, as an original research manufacturer, it is understandable that it has paid huge R&D expenses. The price for one month's usage is NT$/piece (it is also sold in Hong Kong, it costs HKD, and the price is about the same after discounting). (: At present, it seems that Roche Tarceva can also apply for free medicines from the China Charity Federation, but you must first purchase Roche medicines for more than six months).